Neurotoxins cause biochemical and molecular events which indicate early stage effects in exposed persons well before or well below the induction of overt disease. Monitoring these early events may represent a valid approach to developing markers of neurotoxicity in individuals exposed to environmental chemicals. In neurotoxicology, the use of biochemical markers is more problematic compared to other ¢elds due to the complexity of central nervous system function, the multistage nature of neurotoxic events, and the inaccessibility of target tissue. Nevertheless, new biochemical assays have been developed in recent years to assess exposure, subclinical effects, and susceptibility to neurotoxic disorders. This paper reviews novel biomarkers of neurotoxicity and discusses perspectives and limitations of their use in occupational and environmental medicine.

Assessing effects of neurotoxic pollutants by biochemical markers.

MANZO, LUIGI;
2001-01-01

Abstract

Neurotoxins cause biochemical and molecular events which indicate early stage effects in exposed persons well before or well below the induction of overt disease. Monitoring these early events may represent a valid approach to developing markers of neurotoxicity in individuals exposed to environmental chemicals. In neurotoxicology, the use of biochemical markers is more problematic compared to other ¢elds due to the complexity of central nervous system function, the multistage nature of neurotoxic events, and the inaccessibility of target tissue. Nevertheless, new biochemical assays have been developed in recent years to assess exposure, subclinical effects, and susceptibility to neurotoxic disorders. This paper reviews novel biomarkers of neurotoxicity and discusses perspectives and limitations of their use in occupational and environmental medicine.
2001
The Pharmacology/Toxicology category covers resources on all aspects of clinical pharmacology and toxicology including psycho-pharmacology, pharmacokinetics, pharmacotherapy, drug monitoring and drug safety, chemotherapy, clinical and hospital pharmacy, and clinical trials.
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
85
31
36
6
Studio condotto in collaborazione con University of South Florida Department of Neurology, Tampa, FL USA. Finanziamento CEE, VI Programma Quadro
Neurotoxicity; biomarkers; pollutants; biomonitoring; metals
4
info:eu-repo/semantics/article
262
Manzo, Luigi; Castoldi, Af; Coccini, T; Prockop, Ld
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/110786
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact